Yutrepia - Drug Details
๐Ÿ“Š Estimates Yutrepia Dialyzability By Different_Modalities

Yutrepia

Complete Drug Information

Drug Name
Yutrepia
Trade Names
Remodulin, Orenitram, Tyvaso
Pregnancy Category
AU: B3
Bioavailability
~100%
Routes of Administration
Subcutaneous, intravenous, inhalation,Oral
Metabolism
Substantially metabolized by the liver
Elimination
4 hours
Excretion
Urine (79% of administered dose is excreted as 4% unchanged drug and 64% as identified metabolites); feces (13%)
Formula
C23H34O5
Molar Mass
390.52
Volume of Distribution
C23H34O5

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.